On the other hand, we have to keep in mind that p16 immunoreactivity may also be observed in not HPV-related neoplasms as high grade serous carcinomas or leiomyosarcomas among gynecological malignancies, and poorly differentiated NENs of other sites [21,22,23]. Here, CDKN2A is linked to leiomyosarcoma.